The structural collagen improvements are long-lasting, but skin continues to age and new stretching forces can create new marks
GLP1 + Cagrilintide Peptide Blend Research Applications & Key Findings Obesity Management Research Landmark REDEFINE 1 Trial Non-Diabetic Obesity The Phase 3a REDEFINE 1 trial, published in 2025 in The New England Journal of Medicine, enrolled 3,417 adults without diabetes who had obesity or overweight with comorbidities
Meanwhile, research on synergistic effects with other anti-aging substances will be further deepened, providing important support for establishing multi-target, multi-pathway anti-aging intervention systems
Weight loss was never the whole picture for me
Q10: Who should avoid GHK-Cu
Reducing dose of insulin secretagogue or insulin may be necessary